QURE

uniQure N.V. QURE

NasdaqSmall CapHealthcare
InternationalScored off the official board: an annual-only filer, so this data lags a domestic quarterly filer.

13F Pro quality score

Rank #2,898 of 2,925

Why it scores 8Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$5.84M

Quarter to Jun 30

Net income

$-81.06M

Quarter to Jun 30

Free cash flow

$-29.05M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$3.01B total
Avoro Capital Advisors LLC
$309.88M+12.9%
JPMORGAN CHASE & CO
$230.81M+71.6%
RTW INVESTMENTS, LP
$181.55M+52.4%
STATE STREET CORP
$133.75M+28.5%
abrdn plc
$131.18M-46.3%
BlackRock, Inc.
$86.48M+8.3%
ORBIMED ADVISORS LLC
$83.25M-15.4%
JANE STREET GROUP, LLC
$74.18M+153.2%
JENNISON ASSOCIATES LLC
$71.92M+26.6%
Boxer Capital Management, LLC
$69.24M+127.1%
GOLDMAN SACHS GROUP INC
$67.98M+16.8%
TWO SIGMA INVESTMENTS, LP
$67.34M-45.4%
Two Seas Capital LP
$66.39M+10.9%
FMR LLC
$58.50M-27.2%
MAK CAPITAL ONE LLC
$56.75M+179.2%
MPM BioImpact LLC
$56.46M-10.5%
MORGAN STANLEY
$49.13M+191.3%
Vestal Point Capital, LP
$43.07M+160.4%
MAVERICK CAPITAL LTD
$42.62M+32.6%
CITADEL ADVISORS LLC
$41.93M+125.0%
Fiera Capital Corp
$41.88M+11.3%
Integral Health Asset Management, LLC
$41.45M0.0%
GEODE CAPITAL MANAGEMENT, LLC
$39.66M+7.0%
Longaeva Partners L.P.
$37.06MNew
VANGUARD CAPITAL MANAGEMENT LLC
$35.92M+12.2%
See all 255 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

ROIC

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Debt/Equity

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/QURE

Earnings Per Share

13fpro.ai/company/QURE

Loading ratio trend…

QURE key financials by period

Reported revenue, net income and operating margin by fiscal year, from uniQure N.V.'s annual filings on SEC EDGAR.

uniQure N.V. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$16.1M$-199.0M—
FY 2024$27.1M$-239.6M—
FY 2023$15.8M$-308.5M—
FY 2022$106.5M$-126.8M-134.4%
FY 2021$524.0M$329.6M59.3%
FY 2020$37.5M$-125.0M—
Source: QURE filings on SEC EDGAR →

Companies similar to QURE

Ranked by quality-factor profile and overlapping institutional ownership, from the latest 13F filings and SEC financials.

QURE insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About uniQure N.V. (QURE): stock profile, AI score and financials

uniQure N.V. (QURE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores QURE at 8.0/100 on a composite quality score built from its SEC filings, placing it at rank #2,898 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), uniQure N.V. reports quarterly revenue of $5.8M, net income of $-81.1M, free cash flow of $-29.0M. QURE trades on the Nasdaq exchange and files with the SEC under CIK 1590560. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate QURE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for uniQure N.V. directly from SEC EDGAR.

SEC EDGAR: CIK 1590560 →